NOTES PAYABLE (Details Narrative) (USD $)	12 Months Ended						0 Months Ended		12 Months Ended	0 Months Ended		3 Months Ended		0 Months Ended			0 Months Ended	1 Months Ended	12 Months Ended	3 Months Ended		0 Months Ended		12 Months Ended		0 Months Ended	12 Months Ended	0 Months Ended			12 Months Ended		0 Months Ended				12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Jul. 03, 2013	Jun. 21, 2013	Dec. 31, 2004 Ben Franklin Note [Member]	Dec. 31, 1992 Ben Franklin Note [Member]	Jan. 18, 2013 G-Max Trust Convertible Note Payable [Member]	Jun. 11, 2012 G-Max Trust Convertible Note Payable [Member]	Mar. 31, 2014 G-Max Trust Convertible Note Payable [Member]	Oct. 25, 2012 G-Max Trust Zero Coupon Secured Promissory Note [Member]	Apr. 02, 2012 Gemini Convertible Note [Member]	Dec. 31, 2012 Gemini Convertible Note [Member]	Mar. 31, 2014 Gemini Convertible Note [Member]	Jun. 11, 2012 Gemini Convertible Note II [Member]	Jun. 26, 2013 Gemini Convertible Note II [Member]	Mar. 31, 2013 Gemini Convertible Note II [Member]	Jun. 26, 2013 Secured Convertible Promissory Note [Member]	Dec. 31, 2013 Secured Convertible Promissory Note [Member]	Mar. 31, 2014 Secured Convertible Promissory Note [Member]	Jun. 30, 2013 Secured Convertible Promissory Note - Gemini Note II Replacement [Member]	Jun. 26, 2013 Secured Convertible Promissory Note - Gemini Note II Replacement [Member]	Jun. 26, 2013 Convertible Notes Payable [Member]	Dec. 31, 2012 Convertible Notes Payable [Member]	Mar. 31, 2014 Convertible Notes Payable [Member]	Mar. 31, 2013 Convertible Notes Payable [Member]	Mar. 26, 2014 Convertible Notes Payable - Amended [Member]	Mar. 31, 2014 Convertible Notes Payable - Amended [Member]	Jun. 26, 2013 12% Convertible Debentures [Member]	Apr. 05, 2013 12% Convertible Debentures [Member]	Nov. 30, 2010 Drug Wholesaler Notes Payable [Member]	Mar. 31, 2014 Drug Wholesaler Notes Payable [Member]	Mar. 31, 2013 Drug Wholesaler Notes Payable [Member]	Jul. 15, 2012 Drug Wholesaler Notes Payable 2 [Member]	May 01, 2011 Drug Wholesaler Notes Payable 2 [Member]	Mar. 31, 2014 Drug Wholesaler Notes Payable 2 [Member]	Mar. 31, 2013 Drug Wholesaler Notes Payable 2 [Member]	Mar. 31, 2014 Notes Payable to Related Party [Member]	Mar. 31, 2013 Notes Payable to Related Party [Member]
Debt fair value						$ 205,000				$ 588,000
Debt face amount						777,902		500,000		588,000	1,000,000			500,000			6,502,158				613,271		600,000						575,000	132,741				147,866
Effective stated interest rate						3.00%		10.00%			10.00%			10.00%			0.00%						10.00%						12.00%						12.00%		10.00%
Debt discount					572,902												539,395						426,000
Interest rate method, percentage of face amount					46.00%
Common Stock Issued for Financings, Shares								29,412		10,353	58,824			29,412									35,294
Gross proceeds from issuance of debt								500,000		500,000	1,000,000			500,000			5,300,000						600,000						575,000
Debt maturity date								Apr. 01, 2013		Oct. 25, 2013							Dec. 26, 2013						Mar. 26, 2014			Jun. 26, 2014
Debt conversion price (in dollars per share)								$ 9.35			$ 4.25			$ 9.35			$ 8.50						$ 9.35			$ 6.00			$ 8.50
Stock price								$ 12.58			$ 4.25												$ 12.07			$ 6.28
Common Stock Issued for Financings, value		1,592,000						370,000			250,000												426,000
Debt issuance costs								370,000			250,000						286,349		152,000				67,500						67,000
Amortization of debt issuance costs	792,431	1,305,418							370,000															354,082	139,418
Unamortized debt issuance costs									0
Conversion Feature Derivative, at fair value		162,456						172,727				1,840,000		169,455	100,819	162,456							174,545			25,000
Effective annual interest rate									111.50%				46.10%				199.60%							107.00%			196.00%					5.25%
Shares issued in debt conversion							53,729					252,552						22,787										12,235
Accrued interest							2,361					73,343			51,944													173,000									79,776	72,655
Financing threshold for note maturity										2,000,000
Change in Conversion Feature Liability Fair Value	(2,985,007)	1,390,292										354,800						2,398,280		(61,637)
Warrants																	764,960		794,960			22,058	22,058
Warrants exercisable period																	5 years					5 years
Warrants exercise price (in dollars per share)			5.10	3.40													12.155	5.95				12.16
Percentage of closing price compare to exercise price																	110.00%
Down-round protection derivative debt		50,545															3,564,483		378,502
Warrant call notice percentage of warrant exercise price																		250.00%
Warrant call notice exercise price																		14.875
Average fair value of warrants (in dollars per share)																			$ 2.329
Average fair value of anti-dilution warrants (in dollars per share)																			$ 1.2002
Debt converted into shares	297,687	3,415,704					500,000					1,000,000						193,687										104,000
Repayments of notes payable	6,838,501	539,800																6,308,471										644,000			22,725						97,122
Early payment fee																		15.00%
Early payment fee recorded as interest expense	8,626,162	2,333,982																946,271
Final payment																		7,254,742															7,866
Warrants issued to placement agents																	49,673
Amortization of conversion feature																								117,003	57,542		10,203
Gain on debt extinguishment	198,864																									198,864
Net carrying value of notes																											383,339
Interest rate variable basis description																														Prime
Spread on variable basis																														2.00%
Frequency of periodic payment																														Monthly				Monthly
Periodic payment																														10,000				10,000
Balance due on note	38,653	97,683																													0	22,725			38,653	94,463
Notes payable to a related party		$ 97,122																																			$ 0	$ 97,122